Studies, White Papers
   
 
Barrier to Microbial Ingress/ Reduction in Infection (click to expand/contract)
Garcia, R. et al. A Study of the Effects on Bacteremia and Sharps Injury Rates after Introduction of an Advanced Luer Activated Device (LAD) for Intravascular Access in a Large Hospital Setting.
This study tracked bloodstream infection rates and needlestick injuries after converting to the Flolink device. The Flolink and MaxPlus have identical specifications and geometry. They are the same product with the exception of color.Download Pdf

Lange Victor, Tarwater Janice. Infection risk associated with a closed luer access device.
Submitted for publication
The purpose of this study was to ascertain whether a needleless connector, when microbiologically challenged, can be thereafter decontaminated with 70% IPA and maintain a physical barrier. Connectors were challenged for 3 consecutive days, 24 inoculations per day and 24 access per day, 8 of which per static insertions. Download Pdf

Eight Day Microbial Challenge of the MaxPlus Positive Displacement Connector

The purpose of this study was to microbiologically challenge the MaxPlus valve over an extended 8 day period. The extended microbial challenge test results indicate that, in all cases, the MaxPlus continued to provide a physical barrier to contamination for an eight day period. Download Pdf

Comparison of Contamination Rates among Needleless Access Devices in a Simulated Clinical Use - MaxPlus and ICU Clave®.

The MaxPlus and the ICU Medical Clave device were challenged to compare device susceptibility to contamination during multiple activations. Download Pdf

The Use of MaxPlus to Assist in the Prevention and Reduction of BSI's: Results from Two Facilities

Infection Control Professionals from 2 major (500 beds, 523 beds) hospitals tracked CLBSI's before and after implementation of the MaxPlus valve to measure the effectiveness of implementing the MaxPlus as tool to assist in CLBSI prevention. Download Pdf
Reduction in Occlusions (click to expand/contract)
Clot Case Study
For lines that are intermittent and will not have fluid movement for a period of time, any negative reflux into the line at disconnection can potentially lead to a clot like the one discussed in this report.Download Pdf

Lenhart Cheryl, BSN, HRM. Continued Studies in Preventing Complications of Central Venous Access Devices (CVAD's)

A total of 32 patients with central catheters were studied. The purpose of the study was to determine if a positive displacement device assists in maintaining catheter patency. A total of 316 access attempts utilizing the MaxPlus positive displacement device were documented. There is no question that positive displacement adapters, when used in conjunction with preventative measures, are a major factor in reducing complications with CVAD's. Download Pdf

Tarwater Janice, RN. Impact of Positive Pressure versus Simple Valve Needleless Connector on Occlusion in Central Venous Catheters in Children: A Prospective Trial

The study demonstrates that the MaxPlus positive displacement device reduced occlusion rate by 40%.
Download Pdf
Product Performance (click to expand/contract)
MaxPlus Low Flush White Paper
The purpose of this study was to determine if the MaxPlus can be effectively cleared of residue when utilizing lower than normal flush volumes. Download Pdf

MaxPlus Needleless IV Connector Flow Rate Performance
The purpose of this study is to determine the flow rate of needleless connectors and their effect on catheter flow rate in order to provide clinicians with an accurate assessment of needleless access device flow rates and capabilities with regard to intravenous fluid delivery. Download Pdf

Blood Sampling Hemolysis Study for the MaxPlus

The purpose of this study was to determine if the MaxPlus causes statistically significant hemolysis during blood aspiration. Download Pdf

Blood Transfusion Hemolysis Study for the MaxPlus

The purpose of this study was to ascertain if the MaxPlus causes statistically significant hemolysis during blood transfusion through the MaxPlus device. Download Pdf

MaxPlus 72 Hour Activation Testing

The purpose of this test was to evaluate the performance of the MaxPlus connectors during and after 204 activations, with the administration of various fluids through the device over a 72 Hour period.
Download Pdf
 
Victor Lange INS Winner
Andre Schotte INS Winner
Andre Schotte INS Winner
     
Victor Lange INS Winner
Andre Schotte INS Winner
Andre Schotte INS Winner


Andre Schotte INS Winner
Victor Lange INS Winner
   
Small Steps Big Benefits
Small Steps Big Benefits

Managing Infection Control

 

Studies, White Papers
SHEA / IDSA Strategies
  88. Maragakis et. al.
89. Field et. al.
90. Salgado et. al.
  91. Rupp et. al.
  Costello et. al.
  Garcia et. al.
  Letter to the editor
 
 
The MaxPlus Clear Connector
MaxPlus is the fastest growing needleless connector on the market today. As evidence to its success the MaxPlus is being utilized in a number of facilities who in 2006 were awarded Honor Roll status by the U.S. News and World Report as 'America's Best Hospitals." The nation's top facilities are using the MaxPlus for two main reasons; it helps prevent Catheter Related Blood Stream infections (CRBSIs) and catheter line occlusions. Reducing these two complications improves patient outcomes.
more details >>
 
 
 
2007 Medegen, Inc. , all rights reserved.
MaxPlus and Maximus are registered trademarks of Medegen, Inc.